Celltech Medeva Hepacare Hep B Vaccine Targeted For End-2000 U.K. Launch
Executive Summary
Celltech Medeva's three-antigen hepatitis B vaccine Hepacare is slated for a late-2000 U.K. launch following a March 16 recommendation by EMEA's Committee for Proprietary Medicinal Products.